UBS Group’s Cue Biopharma CUE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $200K | Buy |
292,583
+231,270
| +377% | +$158K | ﹤0.01% | 5486 |
|
|
2025
Q1 | $55.9K | Buy |
61,313
+2,999
| +5% | +$2.73K | ﹤0.01% | 6219 |
|
|
2024
Q4 | $63.6K | Sell |
58,314
-15,861
| -21% | -$17.3K | ﹤0.01% | 5931 |
|
|
2024
Q3 | $56.2K | Buy |
74,175
+15,159
| +26% | +$11.5K | ﹤0.01% | 5540 |
|
|
2024
Q2 | $73.2K | Sell |
59,016
-33,951
| -37% | -$42.1K | ﹤0.01% | 5255 |
|
|
2024
Q1 | $176K | Sell |
92,967
-6,294
| -6% | -$11.9K | ﹤0.01% | 4798 |
|
|
2023
Q4 | $262K | Buy |
99,261
+20,119
| +25% | +$53.1K | ﹤0.01% | 4434 |
|
|
2023
Q3 | $182K | Sell |
79,142
-1,170
| -1% | -$2.69K | ﹤0.01% | 4319 |
|
|
2023
Q2 | $293K | Buy |
80,312
+22,283
| +38% | +$81.3K | ﹤0.01% | 4205 |
|
|
2023
Q1 | $207K | Buy |
58,029
+33,884
| +140% | +$121K | ﹤0.01% | 4323 |
|
|
2022
Q4 | $68.8K | Hold |
24,145
| – | – | ﹤0.01% | 5320 |
|
|
2022
Q3 | $54K | Sell |
24,145
-4,276
| -15% | -$9.56K | ﹤0.01% | 5211 |
|
|
2022
Q2 | $71K | Buy |
28,421
+2,736
| +11% | +$6.84K | ﹤0.01% | 4667 |
|
|
2022
Q1 | $126K | Sell |
25,685
-83,614
| -77% | -$410K | ﹤0.01% | 4722 |
|
|
2021
Q4 | $1.24M | Buy |
109,299
+50,709
| +87% | +$573K | ﹤0.01% | 3280 |
|
|
2021
Q3 | $854K | Buy |
58,590
+31,573
| +117% | +$460K | ﹤0.01% | 3367 |
|
|
2021
Q2 | $315K | Sell |
27,017
-25,405
| -48% | -$296K | ﹤0.01% | 4046 |
|
|
2021
Q1 | $640K | Buy |
52,422
+29,887
| +133% | +$365K | ﹤0.01% | 3747 |
|
|
2020
Q4 | $282K | Buy |
22,535
+940
| +4% | +$11.8K | ﹤0.01% | 4055 |
|
|
2020
Q3 | $325K | Hold |
21,595
| – | – | ﹤0.01% | 3695 |
|
|
2020
Q2 | $529K | Sell |
21,595
-9,360
| -30% | -$229K | ﹤0.01% | 3330 |
|
|
2020
Q1 | $439K | Sell |
30,955
-27,868
| -47% | -$395K | ﹤0.01% | 3320 |
|
|
2019
Q4 | $933K | Buy |
58,823
+10,310
| +21% | +$164K | ﹤0.01% | 3404 |
|
|
2019
Q3 | $409K | Buy |
48,513
+12,194
| +34% | +$103K | ﹤0.01% | 3876 |
|
|
2019
Q2 | $326K | Buy |
36,319
+5,947
| +20% | +$53.4K | ﹤0.01% | 3808 |
|
|
2019
Q1 | $235K | Sell |
30,372
-6,983
| -19% | -$54K | ﹤0.01% | 3770 |
|
|
2018
Q4 | $175K | Buy |
37,355
+11,243
| +43% | +$52.7K | ﹤0.01% | 4213 |
|
|
2018
Q3 | $236K | Buy |
26,112
+2,956
| +13% | +$26.7K | ﹤0.01% | 4116 |
|
|
2018
Q2 | $275K | Buy |
23,156
+19,461
| +527% | +$231K | ﹤0.01% | 3914 |
|
|
2018
Q1 | $52K | Buy |
+3,695
| New | +$52K | ﹤0.01% | 4836 |
|